Tuesday, May 13, 2025
The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Perspectives
Health Equity
Research
New Approvals
Health Policy
About Us
Submit Articles
Menu
General
FDA Approves Alectinib for Adjuvant Treatment in Non-Small Cell Lung Cancer
May 16, 2024
By Editorial Team
The FDA approves a new drug for HER2-positive gastric or gastroesophageal junction adenocarcinoma expressing PD-L1
March 21, 2025
